American Association for Clinical Chemistry (AACC)

Two New Tests Could Lower the Coronavirus Mortality Rate by Improving Treatment for Severely Ill COVID-19 Patients

Findings to be discussed at the virtual 2020 AACC Annual Scientific Meeting

Newswise — CHICAGO – A new study shows that a first-of-its-kind rapid test could identify which COVID-19 patients are responding to drug treatments and which patients are still deteriorating and need higher doses of medication. Findings on this method and on a second test that could predict COVID-19 severity were presented today at the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo. 

A Test That Shows If COVID-19 Treatment Is Working 

Studies are now showing that drugs known as corticosteroids reduce the risk of death in critically ill COVID-19 patients by one-third. In spite of the promise of these drugs, though, clinicians still have concerns about their potential side effects. Corticosteroids work by dampening the activity of a patient’s immune system to prevent it from attacking and damaging the lungs. Clinicians therefore worry that prescribing these drugs either too early or at too high a dosage could worsen a patient’s condition by hindering the body’s ability to clear the virus. 

A team of researchers led by Tahel Ilan Ber, MD, and Eran Eden, PhD, of MeMed, and Shaul Lev, MD, of the Rabin Medical Center in Israel, have now demonstrated that MeMed’s 15-minute blood test for the protein interferon gamma induced protein 10 (IP-10) could help guide treatment with corticosteroids. Using this test, the researchers measured IP-10 levels twice a day over the course of a month in 52 SARS-CoV-2 positive patients, 26 of whom developed severe COVID-19. This revealed that severe patients had very high median IP-10 levels (1,190 pg/mL) compared to the median IP-10 levels of the non-severe group (328 pg/mL). In 17 of the severe patients treated with corticosteroids, though, median IP-10 levels fell from 2,961 pg/mL to 372 pg/mL within 3-5 days. Only two of these patients eventually died of COVID-19-related complications, and both of them exhibited IP-10 flare-ups of >1,000 pg/mL after initiation of corticosteroids.

“Our findings show that IP-10 testing could be used to identify patients who are not responding to standard corticosteroid regimens and who need more aggressive treatment—something that physicians were afraid to resort to before, because they didn’t know what effect it would have,” said Dr. Ilan Ber. 

Predicting COVID-19 Severity Early 

Another major challenge in the fight against COVID-19 has simply been ensuring that hospitals have enough ICU beds and ventilators for patients who need intensive care. 

Two different research teams have now shown that a blood test for calprotectin could predict which patients are at risk of decline, enabling hospitals to better allocate essential resources. Using this test, the first team, led by Aleksandra Mandic Havelka, PhD, from Karolinska Institute and Gentian Diagnostics in Stockholm, Sweden, found that ICU patients with COVID-19 had significantly higher calprotectin levels compared with ICU patients without COVID-19. The second team, led by Luis García de Guadiana-Romualdo, PhD, of Hospital Universitario Santa Lucía in Cartagena, Spain, then found that calprotectin levels were significantly higher in COVID-19 patients who required mechanical ventilation and/or died compared with other non-severe COVID-19 patients. 

The second team also compared the calprotectin test’s performance with that of other tests for COVID-19 severity that are currently in use. Out of the other tests they studied, they found that a test for C-reactive protein (CRP) was the only one that predicted both patient need for mechanical ventilation and mortality as accurately as calprotectin. 

“The important difference between CRP and calprotectin is that calprotectin is a much faster biomarker for inflammation and infection, and an earlier indicator that a patient is getting worse,” said Dr. Havelka, who also worked on the second study. “This means that calprotectin is better suited for making urgent decisions about which COVID-19 patients need to be prioritized and treated with the optimal level of care.” 

Abstract Information

AACC Annual Scientific Meeting registration is free for members of the media. Reporters can register online here: https://www.xpressreg.net/register/aacc0720/media/landing.asp 

Abstract B-366: Use of real-time IP-10 measurements for identification and monitoring of the dysregulated immune response in COVID-19 patients 

Abstract B-363: Plasma calprotectin levels are increased in COVID-19 patients admitted to ICU and correlate with endothelial cell damage 

Abstract B-365: Circulating levels calprotectin for prediction of disease severity in hospitalized COVID-19 patients 

About the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo

The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from December 13-17, all available on an online platform. This year, there is a concerted focus on the latest updates on testing for COVID-19, including a talk with current White House Coronavirus Task Force testing czar, Admiral Brett Giroir. Plenary sessions include discussions on using artificial intelligence and machine learning to improve patient outcomes, new therapies for cancer, creating cross-functional diagnostic management teams, and accelerating health research and medical breakthroughs through the use of precision medicine.

At the virtual AACC Clinical Lab Expo, more than 170 exhibitors will fill the digital floor with displays and vital information about the latest diagnostic technology, including but not limited to SARS-CoV-2 testing, mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation. 

About AACC

Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.

 

 

 



Filters close

Showing results

110 of 6054
access_time Embargo lifts in 2 days
Embargo will expire: 26-Jul-2021 11:00 AM EDT Released to reporters: 23-Jul-2021 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jul-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: NIH Chooses University of Miami Miller School of Medicine to Head Project for Its Safe Return to In-Person School Initiative
Released: 23-Jul-2021 12:15 PM EDT
NIH Chooses University of Miami Miller School of Medicine to Head Project for Its Safe Return to In-Person School Initiative
University of Miami Health System, Miller School of Medicine

The University of Miami Miller School of Medicine is helping to lead a National Institutes of Health (NIH) COVID-19 testing initiative to safely return children to in-person school.

Released: 23-Jul-2021 11:40 AM EDT
New 'Atlas' Charts How Antibodies Attack Spike Protein Variants
Brigham and Women’s Hospital

As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions of the virus.

23-Jul-2021 8:55 AM EDT
COVID Variants and a Surge Among the Unvaccinated: Live Expert Panel for July 23rd, 2021
Newswise

Panelists will discuss the threat posed by new COVID variants and continued vaccine hesitancy.

Released: 22-Jul-2021 4:05 PM EDT
COVID-19: Patients with Malnutrition May Be More Likely to Have Severe Outcomes
Scientific Reports

Adults and children with COVID-19 who have a history of malnutrition may have an increased likelihood of death and the need for mechanical ventilation, according to a study published in Scientific Reports.

access_time Embargo lifts in 2 days
Embargo will expire: 27-Jul-2021 4:05 PM EDT Released to reporters: 22-Jul-2021 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-Jul-2021 4:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 26-Jul-2021 4:05 PM EDT Released to reporters: 22-Jul-2021 2:45 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jul-2021 4:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Jul-2021 2:35 PM EDT
New Insights Into Uncontrolled Inflammation in COVID-19 Patients
Queen Mary University of London

In a new study, published recently in the journal Circulation Research, scientists discover how the production of protective molecules known as specialised pro-resolving mediators (SPM) is altered in patients with COVID-19.

Released: 22-Jul-2021 2:30 PM EDT
度假旅行者需要了解的COVID-19相关信息
Mayo Clinic

许多人会利用国家法定假日出门旅行或举办聚会。由于仍有许多人需要接种COVID-19疫苗以及传染性更强的Delta变种疫苗,因此健康专家建议,如果您计划旅行或召集很多人聚会,请务必谨慎。


Showing results

110 of 6054

close
2.01015